Zweig DiMenna Associates LLC purchased a new position in Cross Country Healthcare, Inc. (NASDAQ:CCRN – Free Report) during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund purchased 376,688 shares of the business services provider’s stock, valued at approximately $6,841,000. Zweig DiMenna Associates LLC owned approximately 1.14% of Cross Country Healthcare as of its most recent SEC filing.
Several other hedge funds and other institutional investors also recently made changes to their positions in CCRN. Jane Street Group LLC raised its holdings in Cross Country Healthcare by 337.6% in the third quarter. Jane Street Group LLC now owns 181,492 shares of the business services provider’s stock worth $2,439,000 after buying an additional 140,013 shares during the last quarter. PDT Partners LLC bought a new position in Cross Country Healthcare in the 3rd quarter valued at approximately $856,000. Barclays PLC raised its position in Cross Country Healthcare by 117.5% in the 3rd quarter. Barclays PLC now owns 80,277 shares of the business services provider’s stock worth $1,078,000 after buying an additional 43,372 shares during the last quarter. Royce & Associates LP lifted its stake in Cross Country Healthcare by 51.4% during the 3rd quarter. Royce & Associates LP now owns 1,132,566 shares of the business services provider’s stock valued at $15,222,000 after acquiring an additional 384,374 shares during the period. Finally, Systematic Financial Management LP boosted its holdings in shares of Cross Country Healthcare by 8.5% during the 3rd quarter. Systematic Financial Management LP now owns 1,662,730 shares of the business services provider’s stock valued at $22,347,000 after acquiring an additional 130,746 shares during the last quarter. Hedge funds and other institutional investors own 96.03% of the company’s stock.
Analyst Upgrades and Downgrades
Several research analysts have recently weighed in on CCRN shares. Benchmark cut shares of Cross Country Healthcare from a “strong-buy” rating to a “hold” rating in a report on Wednesday, December 4th. StockNews.com began coverage on shares of Cross Country Healthcare in a research note on Thursday. They set a “hold” rating for the company. William Blair downgraded Cross Country Healthcare from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, December 4th. Truist Financial upped their price objective on Cross Country Healthcare from $15.00 to $18.61 and gave the company a “hold” rating in a research report on Thursday, December 5th. Finally, Barrington Research reissued a “market perform” rating on shares of Cross Country Healthcare in a research report on Tuesday, December 10th. Five investment analysts have rated the stock with a hold rating, According to MarketBeat, the stock has an average rating of “Hold” and a consensus target price of $18.54.
Cross Country Healthcare Stock Performance
NASDAQ:CCRN opened at $18.28 on Friday. Cross Country Healthcare, Inc. has a 52-week low of $9.58 and a 52-week high of $23.15. The firm has a market capitalization of $601.61 million, a PE ratio of -365.43, a P/E/G ratio of 3.34 and a beta of 0.46. The stock has a 50-day simple moving average of $15.99 and a two-hundred day simple moving average of $14.59.
About Cross Country Healthcare
Cross Country Healthcare, Inc provides talent management and other consultative services for healthcare clients in the United States. The company’s Nurse and Allied Staffing segment provides traditional staffing, recruiting, and value-added total talent solutions, including temporary and permanent placement of travel and local nurse and, allied professionals; temporary placement of healthcare leaders within nursing, allied, physician, and human resources; vendor neutral and managed services programs; education healthcare services; in-home care services; and outsourcing services.
Read More
- Five stocks we like better than Cross Country Healthcare
- Special Purpose Acquisition Company (SPAC) What You Need to Know
- Why Energy Transfer Stock Could Soar to New Highs in 2025
- Dividend Capture Strategy: What You Need to Know
- 3 Buy-and-Hold Stocks for Long-Term Growth
- What is a Secondary Public Offering? What Investors Need to Know
- Despite Short-Term Risks Freeport McMoran Worth a Look
Receive News & Ratings for Cross Country Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cross Country Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.